By Maggie Fick and Michael Erman SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...
FDA proposes framework clinical trial designs to guide Bayesian methods, improving efficiency in drug development for rare and pediatric conditions.
The Centre amends drug rules, streamlining approval processes and reducing timelines to enhance clinical research and ...
The MarketWatch News Department was not involved in the creation of this content. Xtalks Life Science Podcast Wraps Up 2025 with Deep Dives into Drug Development, Regulation, Clinical Trials and ...
The Union Ministry of Health and Family Welfare has taken a series of measures including simplification of regulatory processes and reduction of drug approval timelines to facilitate and speed up the ...
The Food and Drug Administration (FDA) has issued a new guidance document entitled “Enhancing Participation in Clinical Trials – Eligibility Criteria, Enrollment Practices, and Trial Decision.” The ...
The Print on MSN
Health ministry eases drug trial rules. Test licences scrapped, CDSCO approval timelines cut by half
Under earlier rules, drugmakers had to get a test licence from CDSCO to manufacture small quantities of drugs for research, ...
The Centre has notified key amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019, in line with the directions ...
A new drug targets the nervous system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results